Amicus Therapeutics (FOLD -20.8%) finishes the day markedly lower after announcing earlier that...

|About: Amicus Therapeutics, Inc. (FOLD)|By:, SA News Editor

Amicus Therapeutics (FOLD -20.8%) finishes the day markedly lower after announcing earlier that it will delay seeking regulatory approval for migalastat HCI, its experimental Fabry disease drug until the second half of next year.